8 completed, 2 unknown. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 8, Unknown 2 |
Follow rebamipide: new trials by email Literature Review of rebamipide trials Research Report on rebamipide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients Rebamipide, Nanoparticulated Rebamipide, Clobetasol Propionate - Rheumatoid Arthritis | Phase 3 | Unknown | Cairo University | 39 | 2020-12-01 | 2023-09-21 |
| Evaluation of Rebamipide and Rabeprazole Effect Associated or Not to Prevent Naproxen-induced Gastric Lesions 550 mg naproxen + 300 mg rebamipide + 20 mg rabeprazole., 550 mg naproxen + placebo + 20 mg rabeprazole, 550 mg naproxen + 300 mg rebamipide + placebo - Gastric Lesion | Phase 3 | Completed | Galeno Desenvolvimento de Pesquisas Clínicas | 32 | 2014-11-12 | 2018-09-05 |
| Confirmatory Study of OPC-12759 Ophthalmic Solution OPC-12759, Placebo - Dry Eye | Phase 3 | Completed | Otsuka Pharmaceutical Co., Ltd. | 209 | 2012-08-01 | 2021-05-05 |
| Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome Rebamipide 2% ophthalmic suspension, Placebo (vehicle) - Dry Eye Syndrome | Phase 3 | Completed | Kubota Vision Inc. | 564 | 2012-06-01 | 2014-05-07 |
| A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 DA-6034, Rebamipide 300mg - Acute Gastritis, Chronic Gastritis | Phase 3 | Unknown | Dong-A Pharmaceutical Co., Ltd. | 492 | 2010-10-01 | 2013-03-22 |
| Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation Rebamipide and Omeprazole, Omeprazole - Gastric Ulcer | Phase 3 | Completed | Otsuka Pakistan Limited | 129 | 2010-10-01 | 2013-02-04 |
| PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity Rebamipide, Misoprostol - Rheumatoid Arthritis, Osteoarthritis | Phase 3 | Completed | Korea Otsuka Pharmaceutical Co., Ltd. | 396 | 2007-12-01 | 2011-11-16 |
| Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis Rebamipide - Dyspepsia, Chronic Gastritis | Phase 3 | Completed | PT Otsuka Indonesia | 55 | 2007-10-01 | 2013-05-15 |
| Study of Rebamipide Eye Drops to Treat Dry Eye Rebamipide 1%, Rebamipide 2%, Placebo - Keratoconjunctivitis Sicca | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 762 | 2004-05-01 | 2026-06-24 |
| A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a Placebo Rebamipide 1%, Rebamipide 2%, Placebo - Keratoconjunctivitis Sicca | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 755 | 2004-05-01 | 2026-06-15 |
Dry Eye Syndromes (4) · Arthritis, Rheumatoid (2) · Keratoconjunctivitis Sicca (2) · Dyspepsia (1) · Osteoarthritis (1) · Spondylitis, Ankylosing (1) · Stomach Ulcer (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · Cairo University (1) · Dong-A Pharmaceutical Co., Ltd. (1) · Galeno Desenvolvimento de Pesquisas Clínicas (1) · Korea Otsuka Pharmaceutical Co., Ltd. (1) · Kubota Vision Inc. (1) · Otsuka Pakistan Limited (1) · Otsuka Pharmaceutical Co., Ltd. (1) · PT Otsuka Indonesia (1)
United States (3) · South Korea (2) · Brazil (1) · Egypt (1) · Indonesia (1) · Japan (1) · Pakistan (1)
Aziz Rani, MD (1) · Byung Chul Yoon, M.D., Ph.D. (1) · Chan Kook Park, M.D., Ph.D. (1) · Dong Ho Lee, M.D.,Ph.D. (1) · Dr. Laeeque Ahmed, Asst. Professor (1) · Eiji Murakami (1) · Gary Foulks, MD (1) · Gilberto De Nucci, Doctor (1) · Hak Yang Kim, M.D., Ph.D. (1) · Hyun Chae Jung, M.D., Ph.D. (1) · Jae Gyu Kim, M.D., Ph.D. (1) · Jeong Seop Moon, M.D., Ph.D. (1) · Jong Sun Rew, M.D., Ph.D. (1) · Ju Yung Cho, M.D., Ph.D. (1)